mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with peroxynitrous acid in 5 studies
| Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) |
|---|---|---|---|---|---|
| 69 | 0 | 42 | 3,303 | 21 | 1,230 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beretz, A; Etienne-Selloum, N; Kane, MO; Sarr, M; Schini-Kerth, VB; Walter, A | 1 |
| Aggarwal, S; Black, SM; Datar, S; Fineman, JR; Fratz, S; Gross, CM; Kalkan, G; Kumar, S; Oishi, P; Schreiber, C | 1 |
| El-Assar, M; Esteban, A; Ferruelo, A; Hurtado, J; Lorente, JA; Martínez-Caro, L; Nin, N; Paula, Md; Rojas, Y; Sánchez, C; Sánchez-Ferrer, A | 1 |
| Al-Owais, MM; Boyle, JP; Dallas, ML; Elies, J; Hettiarachchi, NT; Lippiat, JD; Peers, C; Scragg, JL; Steele, DS | 1 |
| Cao, W; Gao, Y; Lei, Y; Song, M; Sun, X | 1 |
5 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and peroxynitrous acid
| Article | Year |
|---|---|
Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme Inhibitors; Flavonoids; Fluorescent Antibody Technique; Hypertension; Male; Matrix Metalloproteinase 2; Metalloporphyrins; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; Peroxynitrous Acid; Phenols; Polyphenols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Wine | 2008 |
Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Endothelial Cells; Enzyme Activation; Free Radical Scavengers; Hypertension, Pulmonary; Metalloporphyrins; Molsidomine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Peroxynitrous Acid; Polyethylene Glycols; Protein Processing, Post-Translational; Pulmonary Artery; Pulmonary Circulation; Second Messenger Systems; Sheep; Spermine; Superoxide Dismutase; Vasodilation; Vasodilator Agents | 2011 |
Vascular dysfunction in sepsis: effects of the peroxynitrite decomposition catalyst MnTMPyP.
Topics: Acetylcholine; Animals; Aorta; Male; Metalloporphyrins; Microvessels; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Norepinephrine; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Sepsis; Vasodilator Agents | 2011 |
Multiple mechanisms mediating carbon monoxide inhibition of the voltage-gated K
Topics: Animals; Carbon Monoxide; Cell Line; HEK293 Cells; Humans; Hydrogen Peroxide; Kv1.5 Potassium Channel; Metalloporphyrins; Mice; Mitochondria; Mutagenesis, Site-Directed; Nitric Oxide; Peroxynitrous Acid; Reactive Oxygen Species; Recombinant Proteins | 2017 |
Peroxynitrite is a novel risk factor and treatment target of glaucoma.
Topics: Adult; Aged; Animals; Case-Control Studies; Caveolin 1; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Male; Metalloporphyrins; Mice, Knockout; Middle Aged; Peroxynitrous Acid; Risk Factors; Tyrosine | 2020 |